Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dianthus Therapeutics (DNTH) Long-Term Debt Repayments (2023)

Dianthus Therapeutics has reported Long-Term Debt Repayments over the past 1 years, most recently at $377000.0 for Q1 2023.

  • Quarterly results put Long-Term Debt Repayments at $377000.0 for Q1 2023, changed N/A from a year ago — trailing twelve months through Dec 2023 was $377000.0 (changed N/A YoY), and the annual figure for FY2023 was $377000.0, changed.
  • Long-Term Debt Repayments for Q1 2023 was $377000.0 at Dianthus Therapeutics.
  • Over the last five years, Long-Term Debt Repayments for DNTH hit a ceiling of $377000.0 in Q1 2023 and a floor of $377000.0 in Q1 2023.